Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2012
05/22/2012US8183346 Anti-ferroportin 1 monoclonal antibodies and uses thereof
05/22/2012US8183212 Compound having GPR54 agonistic activity
05/22/2012US8182985 Anti-TSG101 antibodies and their uses for treatment of viral infections
05/22/2012US8182983 Method for determining immune system affecting compounds
05/22/2012US8182817 Antibodies to human IL-22
05/22/2012US8182816 Methods of treating cancer
05/22/2012US8182815 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
05/22/2012US8182814 Methods of treating inflammatory airway conditions by inhibition of IL-11 activity
05/22/2012US8182813 Human C-FMS antigen binding proteins
05/22/2012US8182812 Human monoclonal antibodies against CD25
05/22/2012US8182811 Antibodies to CXCL13
05/22/2012US8182810 IL-B30 antibodies
05/22/2012CA2619771C A method for the mass production of immunoglobulin fc region deleted initial methionine residues
05/22/2012CA2619736C Dopaminergic neuron proliferative progenitor cell marker msx1/2
05/22/2012CA2475467C Gene conferring resistance to phytophthora infestans (late-blight) in solanaceae
05/22/2012CA2464947C Combination therapy for treating disease
05/22/2012CA2386865C Diagnosis and therapy of cancer using sgp28-related molecules
05/22/2012CA2304254C Trimerising module
05/22/2012CA2274803C Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
05/18/2012WO2012065055A2 Fusion proteins for hiv therapy
05/18/2012WO2012064842A2 System and method for generating micro-seismic events and characterizing properties of a medium with non-linear acoustic interactions
05/18/2012WO2012064836A1 Methods and compositions for neural disease immunotherapy
05/18/2012WO2012064792A2 Protein complexes for antigen binding and methods of use
05/18/2012WO2012064771A1 Actriia binding agents and uses thereof
05/18/2012WO2012064760A2 Materials and methods for directing an immune response to an epitope
05/18/2012WO2012064682A1 Human antibodies to human tnf-like ligand 1a (tl1a)
05/18/2012WO2012064627A2 Subcutaneously administered anti-il-6 receptor antibody
05/18/2012WO2012064501A1 Hydroxycholesterol immunoassay
05/18/2012WO2012063955A1 Therapeutic agent for arteriosclerosis or arteriosclerotic disorders and diagnostic agent for arteriosclerosis or arteriosclerotic disorders
05/18/2012WO2012063839A1 Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same
05/18/2012WO2012063829A1 Novel gene, and osteoporosis testing method based on single nucleotide polymorphism on fong gene locus
05/18/2012WO2012063048A1 Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
05/18/2012WO2012062945A1 Functionalized boscalid derivatives
05/18/2012WO2012062810A2 Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
05/18/2012WO2012062713A1 Cxcr2 binding polypeptides
05/18/2012WO2012062697A1 Combination therapy for type 1 diabetes
05/18/2012WO2012062596A1 Prevention of adverse effects caused by cd3 specific binding domains
05/18/2012WO2012062094A1 Conjugate of folate and antibody, preparation method and use thereof
05/18/2012WO2012062072A1 Human-mouse chimeric monoclonal antibody against angiostatin receptor and use thereof
05/18/2012WO2012061904A1 Histone protein ubiquitination as a cancer biomarker
05/18/2012WO2012031198A3 Novel antigen binding proteins
05/18/2012WO2012021840A3 Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies
05/18/2012WO2011159847A3 Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
05/18/2012WO2011150994A3 Serum and tissue biomarkers of human hcc
05/18/2012WO2011131178A3 Method for detecting a salmonella infection
05/18/2012WO2011056606A8 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
05/18/2012CA2825083A1 Conjugate of folate and antibody, preparation method and use thereof
05/18/2012CA2820590A1 Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same
05/18/2012CA2817568A1 Cancer therapies and diagnostics
05/18/2012CA2817561A1 System and method for generating micro-seismic events and characterizing properties of a medium with non-linear acoustic interactions
05/18/2012CA2817216A1 Subcutaneously administered anti-il-6 receptor antibody
05/18/2012CA2817202A1 Hydroxycholesterol immunoassay
05/18/2012CA2817132A1 Cxcr2 binding polypeptides
05/18/2012CA2817015A1 Protein complexes for antigen binding and methods of use
05/18/2012CA2817008A1 Actriia binding agents and uses thereof
05/18/2012CA2816799A1 Human antibodies to human tnf-like ligand 1a (tl1a)
05/18/2012CA2816668A1 Prevention of adverse effects caused by cd3 specific binding domains
05/18/2012CA2816394A1 Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
05/18/2012CA2815840A1 Methods and compositions for neural disease immunotherapy
05/17/2012US20120124705 Novel fatty acid desaturases and elongases and uses thereof
05/17/2012US20120124683 Delivery method
05/17/2012US20120123093 Novel surface antigen
05/17/2012US20120122777 Diagnostic agent for ischemic heart disease risk group
05/17/2012US20120122762 186 Human Secreted Proteins
05/17/2012US20120122759 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
05/17/2012US20120122726 Markers for endometrial cancer
05/17/2012US20120122238 VMP-Like Sequences of Pathogenic Borrelia
05/17/2012US20120122206 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
05/17/2012US20120122126 Anti-psk antibody
05/17/2012US20120122125 Anti-t. cruzi antibodies and methods of use
05/17/2012US20120122120 Antibodies against human epo receptor
05/17/2012US20120122118 Monclonal antibodies, hybridomas and methods for use
05/17/2012US20120122114 Immunoassay for the detection of procalcitonin
05/17/2012US20120122076 Purification of antibodies using simulated moving bed chromatography
05/17/2012US20120121646 Vaccine
05/17/2012US20120121638 Polypeptide Derived From Enterococcus And Its Use For Vaccination
05/17/2012US20120121633 Hiv cd4 binding site based covalent immunogen compositions
05/17/2012US20120121620 Anti-estrogen and immune modulator combinations for treating breast cancer
05/17/2012US20120121615 Alaninyl maytansinol antibody conjugates
05/17/2012US20120121610 Therapeutic agent and assay
05/17/2012US20120121609 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
05/17/2012US20120121607 Antibodies to clostridium difficile toxins
05/17/2012US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/17/2012US20120121605 Anti sulfatides and anti sufated proteoglycans antibodies and their use
05/17/2012US20120121603 Compositions And Methods For The Therapy And Diagnosis Of Influenza
05/17/2012US20120121602 Novel proteins
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121600 Pharmaceutical antibody compositions with resistance to soluble cea
05/17/2012US20120121599 Compositions and methods for stem cell delivery
05/17/2012US20120121597 Fusion proteins for hiv therapy
05/17/2012US20120121596 Bispecific anti-her antibodies
05/17/2012US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
05/17/2012US20120121594 Anti-il-6 antibodies for the treatment of arthritis
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121587 Anti-axl antibody
05/17/2012US20120121585 SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121583 Antibodies against human tweak and uses thereof
05/17/2012US20120121579 Treatment of oncostatin m receptor beta mediated heart failure
05/17/2012US20120121577 Antibodies as t cell receptor mimics, methods of production and uses thereof
1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 1494